Q3 2017 Holdings
Filed 2017-11-14 | 63 holdings | $28.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $14.0K | 100,000 | 0.0% |
| DBV Technologies S APut | SPONSORED ADR | 23306J101 | $17.1K | 403,500 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $17.9K | 420,886 | 0.1% |
| Avexis IncPut | COM | 05366U100 | $19.3K | 200,000 | 0.1% |
| Zogenix Inc | COM NEW | 98978L204 | $21.0K | 600,000 | 0.1% |
| Zogenix IncPut | COM NEW | 98978L204 | $22.8K | 650,000 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $27.2K | 1,946,946 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $30.3K | 350,000 | 0.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $2.6M | 500,000 | 9.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.1M | 35,000 | 14.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.7M | 252,534 | 20.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $7.3M | 200,000 | 25.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $8.0M | 275,000 | 28.5% |